Subcutaneous methotrexate versus oral form for the treatment and prophylaxis of chronic plaque psoriasis-Reference-Cited by-同舟云学术

Subcutaneous methotrexate versus oral form for the treatment and prophylaxis of chronic plaque psoriasis

Published:2019-08-20 Issue:5 Volume:32 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Attwa Enayat M.¹^ORCID,Elkot Reham A.¹^ORCID,Abdelshafey Ahmed S.¹,Hafez Amera R.¹²

Affiliation:

1. Faculty of Medicine, Dermatology, Venereology and Andrology DepartmentZagazig University

2. Dermatology, Venereology and Andrology DepartmentNational Institute of Health Hospital Lawrenceville Georgia

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.13051

Reference17 articles.

1. Weekly methotrexate versus daily isotretinoin to treat moderate-to-severe chronic plaque psoriasis: a comparative study

2. The Interplay Between Keratinocytes and Immune Cells in the Pathogenesis of Psoriasis

3. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study

4. Validation on 3D surface roughness algorithm for measuring roughness of psoriasis lesion;Fadzil A.;International Journal of Biomedical and Biology Engineering,2010

5. Current guidelines for psoriasis treatment;Golbari N. M.;Cutis,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular mechanisms underlying methotrexate-induced intestinal injury and protective strategies;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-01

2. Analysis of factors influencing target PASI responses and side effects of methotrexate monotherapy in plaque psoriasis: a multicenter study of 1521 patients;Archives of Dermatological Research;2024-05-25

3. Retrospective Cohort Study Comparing Efficacy and Safety of Pharmacological Intervention and Phototherapy in Moderate to Severe Psoriasis Patients in a Real-World Setting;Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences.;2024-04-01

4. Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients;Expert Opinion on Drug Metabolism & Toxicology;2024-03-28

5. ABCC1, ABCG2 and FOXP3: Predictive Biomarkers of Toxicity from Methotrexate Treatment in Patients Diagnosed with Moderate-to-Severe Psoriasis;Biomedicines;2023-09-19